T-antigen in normal and neoplastic urothelium

Area of Science:

• Urothelial Carcinogenesis
• Tumor Immunology
• Biomarker Discovery

Background:

• The Thomsen-Friedenreich antigen (T-antigen) is a tumor-associated carbohydrate antigen.
• Its expression in normal and neoplastic urothelium is not fully understood.
• Investigating T-antigen expression may reveal insights into bladder cancer progression.

Purpose of the Study:

• To investigate the expression of the T-antigen in normal and neoplastic urothelium.
• To correlate T-antigen expression with clinicopathological features of transitional cell carcinoma (TCC).
• To explore the relationship between T-antigen expression and blood group antigen detectability.

Main Methods:

• Studied 56 patient biopsies (paraffin-processed and fresh frozen).
• Detected T-antigen via peanut agglutinin (PNA) binding using biotin-avidin-peroxidase and red cell adherence tests.
• Correlated findings with light/electron microscopy and blood group antigen detection.

Main Results:

• Spontaneous PNA binding (T-antigen) was absent in normal urothelium.
• Observed in 10% of noninvasive and 65% of invasive TCCs.
• T-antigen expression correlated with invasion and lack of expected blood group antigens.

Conclusions:

• T-antigen expression increases with bladder cancer progression, particularly in invasive stages.
• Spontaneous T-antigen unmasking is linked to invasion and higher metastatic risk.
• T-antigen may serve as a biomarker for aggressive urothelial carcinoma.